ALT
Price
$4.00
Change
+$0.08 (+2.04%)
Updated
Oct 13 closing price
Capitalization
345.97M
28 days until earnings call
TGTX
Price
$34.22
Change
+$0.46 (+1.36%)
Updated
Oct 13 closing price
Capitalization
5.43B
16 days until earnings call
Interact to see
Advertisement

ALT vs TGTX

Header iconALT vs TGTX Comparison
Open Charts ALT vs TGTXBanner chart's image
Altimmune
Price$4.00
Change+$0.08 (+2.04%)
Volume$3.1M
Capitalization345.97M
TG Therapeutics
Price$34.22
Change+$0.46 (+1.36%)
Volume$1.24M
Capitalization5.43B
ALT vs TGTX Comparison Chart in %
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. TGTX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (ALT: $4.00 vs. TGTX: $34.22)
Brand notoriety: ALT and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 109% vs. TGTX: 60%
Market capitalization -- ALT: $345.97M vs. TGTX: $5.43B
ALT [@Biotechnology] is valued at $345.97M. TGTX’s [@Biotechnology] market capitalization is $5.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 6 TA indicator(s) are bullish while TGTX’s TA Score has 6 bullish TA indicator(s).

  • ALT’s TA Score: 6 bullish, 2 bearish.
  • TGTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than TGTX.

Price Growth

ALT (@Biotechnology) experienced а -0.25% price change this week, while TGTX (@Biotechnology) price change was -6.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +80.86%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.43B) has a higher market cap than ALT($346M). TGTX YTD gains are higher at: 13.688 vs. ALT (-44.522). TGTX has higher annual earnings (EBITDA): 97.6M vs. ALT (-88.03M). TGTX has more cash in the bank: 252M vs. ALT (183M). ALT has less debt than TGTX: ALT (15.8M) vs TGTX (254M). TGTX has higher revenues than ALT: TGTX (454M) vs ALT (20K).
ALTTGTXALT / TGTX
Capitalization346M5.43B6%
EBITDA-88.03M97.6M-90%
Gain YTD-44.52213.688-325%
P/E RatioN/A90.05-
Revenue20K454M0%
Total Cash183M252M73%
Total Debt15.8M254M6%
FUNDAMENTALS RATINGS
ALT vs TGTX: Fundamental Ratings
ALT
TGTX
OUTLOOK RATING
1..100
2174
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9835
PRICE GROWTH RATING
1..100
6151
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGTX's Valuation (89) in the Biotechnology industry is in the same range as ALT (96) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's SMR Rating (35) in the Biotechnology industry is somewhat better than the same rating for ALT (98) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew somewhat faster than ALT’s over the last 12 months.

TGTX's Price Growth Rating (51) in the Biotechnology industry is in the same range as ALT (61) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew significantly faster than ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTTGTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCWFX73.201.09
+1.51%
American Funds SMALLCAP World F1
TPYYX9.01N/A
N/A
Touchstone Sands Capital Intl Gr Eq Y
JMNSX16.17N/A
N/A
JPMorgan Research Market Neutral I
TRSGX43.49N/A
N/A
T. Rowe Price Spectrum Mod Gr Allc
LYRCX28.42N/A
N/A
Lyrical US Value Equity C

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+2.04%
ACHV - ALT
52%
Loosely correlated
+0.65%
INDP - ALT
45%
Loosely correlated
+2.81%
KROS - ALT
39%
Loosely correlated
+1.21%
AMRN - ALT
38%
Loosely correlated
+5.16%
CDXS - ALT
36%
Loosely correlated
-3.47%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+1.36%
KRYS - TGTX
41%
Loosely correlated
+1.80%
ARRY - TGTX
36%
Loosely correlated
+0.57%
CLLS - TGTX
36%
Loosely correlated
+9.41%
AXON - TGTX
36%
Loosely correlated
+0.99%
AMRN - TGTX
34%
Loosely correlated
+5.16%
More